Please use this identifier to cite or link to this item:
https://hdl.handle.net/2440/35082
Type: | Journal article |
Title: | Bisphosphonates and the osteonecrosis of the jaw |
Author: | Sambrook, P. Olver, I. Goss, A. |
Citation: | Australian Family Physician, 2006; 35(10):801-803 |
Publisher: | Royal Australian College of General Practitioners |
Issue Date: | 2006 |
ISSN: | 0300-8495 |
Statement of Responsibility: | Philip Sambrook, Ian Olver, Alastair Goss |
Abstract: | Recently an association between bisphosphonate use and a rare dental condition termed ‘osteonecrosis of the jaw’ (ONJ) has been reported. Patients with osteoporosis and Paget disease who take bisphosphonates have a significantly reduced risk of fracture and other skeletal complications. This represents significant health benefits, against which the small risk of ONJ needs to be considered. In patients with bone malignancy, the risk of ONJ needs to be balanced against the benefit of therapy on the underlying malignancy. There are still many uncertainties about this condition. This position paper seeks to summarise what is currently known about ONJ to provide information to medical practitioners and dental practitioners. |
Keywords: | Humans Bone Neoplasms Osteoporosis Osteitis Deformans Osteonecrosis Jaw Diseases Diphosphonates Practice Guidelines as Topic |
Description: | Copyright © 2006 Royal Australian College of General Practitioners Copyright to Australian Family Physician. Reproduced with permission. Permission to reproduce must be sought from the publisher, The Royal Australian College of General Practitioners. |
Published version: | http://www.racgp.org.au/afp/200610/12539 |
Appears in Collections: | Aurora harvest Dentistry publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
hdl_35082.pdf | 244.7 kB | Publisher's PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.